miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1278-1282

  Hasseine, Larbi Kamal ^a,b   Hinault, Charlotte ^a,b,c   Lebrun, Patricia ^a,b   Gautier, Nadine ^a,b   Paul Bellon, Rachel ^a,b   Van Obberghen, Emmanuel ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

FoxO; Liver; MicroRNA

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MESSENGER RNA; MICRORNA; MICRORNA 139; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; LIVER; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; UBIQUITINATION;

ANIMALS; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEPATOCYTES; MICE; MICRORNAS; RNA, MESSENGER;

EID: 70450239585     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.135     Document Type: Article

References (22)

1. Accili D., and Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 (2004) 421-426
2. Buteau J., and Accili D. Regulation of pancreatic beta-cell function by the forkhead protein FoxO1. Diabetes Obes. Metab. 9 Suppl 2 (2007) 140-146
3. Calnan D.R., and Brunet A. The FoxO code. Oncogene 27 (2008) 2276-2288
4. Van Der Heide L.P., Hoekman M.F., and Smidt M.P. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380 (2004) 297-309
5. Gross D.N., Van den Heuvel A.P., and Birnbaum M.J. The role of FoxO in the regulation of metabolism. Oncogene 27 (2008) 2320-2336
6. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
7. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
8. Wightman B., Ha I., and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993) 855-862
9. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., and Kellis M. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434 (2005) 338-345
10. Kato M., and Slack F.J. MicroRNAs: small molecules with big roles-C. elegans to human cancer. Biol. Cell 100 (2008) 71-81
11. Chang T.C., and Mendell J.T. MicroRNAs in vertebrate physiology and human disease. Annu. Rev. Genomics Hum. Genet. 8 (2007) 215-239
12. Costa F.F. Non-coding RNAs: new players in eukaryotic biology. Gene 357 (2005) 83-94
13. El Ouaamari A., Baroukh N., Martens G.A., Lebrun P., Pipeleers D., and Van Obberghen E. MiR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57 (2008) 2708-2717
14. He A., Zhu L., Gupta N., Chang Y., and Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 21 (2007) 2785-2794
15. Valverde A.M., Burks D.J., Fabregat I., Fisher T.L., Carretero J., White M.F., and Benito M. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52 (2003) 2239-2248
16. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
17. Tsuchida A., Yamauchi T., Ito Y., Hada Y., Maki T., Takekawa S., Kamon J., Kobayashi M., Suzuki R., Hara K., Kubota N., Terauchi Y., Froguel P., Nakae J., Kasuga M., Accili D., Tobe K., Ueki K., Nagai R., and Kadowaki T. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279 (2004) 30817-30822
18. Kamagate A., Qu S., Perdomo G., Su D., Kim D.H., Slusher S., Meseck M., and Dong H.H. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 118 (2008) 2347-2364
19. Raabe M., Veniant M.M., Sullivan M.A., Zlot C.H., Bjorkegren J., Nielsen L.B., Wong J.S., Hamilton R.L., and Young S.G. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103 (1999) 1287-1298
20. Huang H., and Tindall D.J. Dynamic FoxO transcription factors. J. Cell. Sci. 120 (2007) 2479-2487
21. Chen X.M. MicroRNA signatures in liver diseases. World J. Gastroenterol. 15 (2009) 1665-1672
22. Baugh L.R., and Sternberg P.W. DAF-16/FOXO regulates transcription of cki-1/Cip/Kip and repression of lin-4 during C. elegans L1 arrest. Curr. Biol. 16 (2006) 780-785